Ascent Industries Co.

ACNT Basic Materials Chemicals

In the quarter to June 2026, revenue grew 37.6%, EPS fell 89.2%, free cash flow fell 97.5% and total debt fell 26.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

13.49 0.06 −0.44%
Market cap
$122.1M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
7/9
Altman Z
5.55
Beneish M
−2.87
Dividend safety
n/a

Insider Decisions trades per month

Total buys 0.14
Total sells 0.02
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — 2 — — — — — — —
Sell — — — — — — — 1 — — — —
Insider Ownership 14.56%

Capital & Financial Ratios $m

Market Cap 122.08
Revenue 83.54
Net Income (4.44)
Free Cash Flow (8.40)
Net Debt (27.43)
Current Ratio 4.33 (at or above 1.5: strong)
Debt/Equity 0.01 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E 0.00
P/S ratio 1.46
P/B ratio 1.53
Past 5Y EPS Growth —
This Y EPS Growth 80.23% (at or above 15%: strong)
Next Y EPS Growth 259.62% (at or above 15%: strong)
Next Y revenue growth (100.00%) (below 0%: weak)
Next 5Y EPS Growth 12.40%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/S against its own 10 years 85.11%
10-year low 10-year high
P/B against its own 10 years 85.99%
10-year low 10-year high
EV/Sales against its own 10 years 89.53%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2018 0.25
0.25
2017 0.13
0.13
2016 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 2 16 58 28
Receivables 27 12 15 24
Inventory 52 6 9 10
Other 3 — — —
89 83 83 65
2023 2024 2025 Q'26
Payables 16 7 5 9
ST’ Debt — — — —
Other — — — —
25 22 12 15

Compound Annual Growth %

10y 5y 3y
Sales (8.16%) (21.78%) (34.11%)
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% (66.00%)
Book Value (0.89%) 1.62% (13.47%)

Revenue $m

Mar Jun Sep Dec Year
’26 19 26 — — —
’25 18 19 20 19 75
’24 28 21 21 10 81
’23 55 50 47 41 193
’22 116 85 78 (17) 262
’21 70 83 86 96 335
’20 75 66 59 56 256
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (5) (2) — — —
’25 (1) (1) 1 0 (1)
’24 0 2 3 9 15
’23 13 5 3 2 23
’22 0 2 (2) 5 6
’21 (1) 6 11 3 19
’20 (1) 0 6 12 18
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (6) (3) — — —
’25 (1) (2) 1 0 (2)
’24 0 2 3 8 14
’23 13 4 2 1 20
’22 (1) 2 (3) 4 2
’21 (1) 6 12 2 19
’20 (1) (1) 5 11 15
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.21) 0.07 — — —
’25 (0.23) 0.65 (0.20) (0.11) 0.09
’24 (0.54) (0.09) (0.61) (0.10) (1.34)
’23 (0.51) (1.44) (1.77) 1.07 (2.63)
’22 0.99 1.06 0.06 0.01 2.12
’21 0.12 0.31 0.87 0.84 2.14
’20 (0.13) (0.77) (1.16) (0.94) (3.00)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 6.42 9.75 12.11 11.45 3.81 7.47 8.12 7.20 8.16 10.76

Analyst estimates 2026–2028

Powerpack
High 11.70 15.30 24.80 19.65 14.25 16.45 19.20 11.56 12.38 16.84
People
People Employees 412 533 607 606 526 707 698 517 452 198
Revenue/emp, $m 0.34 0.38 0.46 0.50 0.49 0.47 0.38 0.37 0.18 0.38
Income, $m
Income, $m Revenue 139 201 281 305 256 335 262 193 81 75
Gross margin, % 12.20 13.96 18.24 10.08 8.85 18.15 16.52 0.79 13.24 22.97
EBT (9) 1 16 (4) (32) 25 12 (41) (11) (6)
EBT margin, % (6.63) 0.73 5.87 (1.23) (12.49) 7.62 4.58 (21.26) (13.34) (7.42)
Net income (7) 1 13 (3) (27) 20 22 (27) (14) 1
Depreciation 7 7 9 11 27 10 8 8 5 4
Per share, $
Per share, $ Revenue 16.02 23.11 31.89 33.97 28.01 35.84 25.61 19.05 7.99 7.77
Earnings (0.82) 0.15 1.49 (0.34) (3.00) 2.17 2.16 (2.63) (1.34) 0.09
Cash flow 0.17 0.26 (2.41) 3.19 1.97 2.04 0.55 2.28 1.45 (0.05)
Capex 2.22 (0.60) (0.84) (0.48) (0.38) (0.01) (0.32) (0.28) (0.11) (0.16)
Free cash flow 2.39 (0.34) (3.25) 2.70 1.59 2.03 0.22 1.99 1.34 (0.21)
Book value 10.24 10.30 11.64 11.86 8.79 11.95 13.12 10.59 9.26 9.02
Shares, m 9 9 9 9 9 9 10 10 10 10
Valuation, ×
Valuation, × P/E 0.00 89.67 11.13 0.00 0.00 7.61 4.19 0.00 0.00 147.18
P/S 0.69 0.58 0.52 0.38 0.28 0.46 0.35 0.51 1.40 2.08
P/B 1.07 1.31 1.43 1.09 0.89 1.38 0.69 0.93 1.21 1.79
EV/Sales 0.78 0.73 0.80 0.63 0.52 0.67 0.62 0.52 1.24 1.36
EV/FCF 5.24 (49.65) (7.87) 7.87 9.11 11.78 71.66 5.02 7.40 (49.34)
Cash, $m
Cash, $m Operating cash flow 2 2 (21) 29 18 19 6 23 15 (1)
Capex 19 (5) (7) (4) (3) 0 (3) (3) (1) (2)
Free cash flow 21 (3) (29) 24 15 19 2 20 14 (2)
Balance, $m
Balance, $m Working capital 65 74 130 107 96 109 137 65 61 71
Total debt 9 26 77 76 61 72 73 1 1 1
Net debt 9 26 74 75 61 70 71 (1) (15) (57)
Shareholders’ equity 89 90 102 107 80 112 134 107 94 87
Returns, %
Returns, % ROA (4.93) 0.90 6.75 (1.25) (11.75) 8.56 8.25 (12.32) (8.76) 0.67
ROIC (5.30) 1.11 7.50 (0.59) (13.73) 9.42 4.42 (21.89) (8.60) (14.55)
ROE (7.72) 1.50 13.63 (2.91) (29.19) 21.10 17.95 (22.04) (13.53) 0.96
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Ascent Industries Co. vs peers in Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
WLKP Westlake Chemical Partners LP $734.5M 12.8× 12.3× −0.01% (below 0%: shrinking) −2.44% (below 0%: shrinking) +866.65% (above 0%: growing) 31.91% 29.39% Compare
TROX Tronox Holdings PLC $565.3M — (loss-making) — (loss-making) +18.74% (above 0%: growing) n/m +241.51% (above 0%: growing) 6.34% (2.42%) Compare
RYAM Rayonier Advanced Materials Inc. $481.0M — (loss-making) — (loss-making) +10.61% (above 0%: growing) n/m +69.92% (above 0%: growing) 6.10% (1.69%) Compare
ASIX AdvanSix $445.5M — (loss-making) 24.1× +2.75% (above 0%: growing) −89.74% (below 0%: shrinking) −49.21% (below 0%: shrinking) 7.38% 2.15% Compare
VHI Valhi, Inc. $415.2M — (loss-making) 7.0× +9.82% (above 0%: growing) +2,500.00% (above 0%: growing) +435.16% (above 0%: growing) 22.56% 9.88% Compare
ASPI ASP Isotopes Inc. $338.8M — (loss-making) — (loss-making) +327.63% (above 0%: growing) n/m −182.92% (below 0%: shrinking) 28.89% (667.48%) Compare
BAK Braskem S.A. $312.3M — (loss-making) — −99.99% (below 0%: shrinking) n/m +611.13% (above 0%: growing) 80.35% 48.61% Compare
ACNT Ascent Industries Co. $122.1M — (loss-making) — (loss-making) +37.61% (above 0%: growing) −89.23% (below 0%: shrinking) −97.54% (below 0%: shrinking) 21.62% (1.02%)
MKD MOLECULAR DATA $74.9M — (loss-making) — (loss-making) −51.50% (below 0%: shrinking) n/m — 0.83% 0.00% Compare
Median of peers $430.4M — 12.3× +6.29% −2.44% +241.51% 14.97% 1.08%

All 17 Chemicals stocks →

Ascent Industries Co. (ACNT) key facts

  • Ascent Industries Co. (ACNT) is a Chemicals company in the Basic Materials sector, listed on Nasdaq.
  • Net income was $867,000.00, or $0.09 per share (basic), a net margin of 1.16%.
  • As of October 16, 2026, ACNT traded at $13.49, a market capitalization of $122.1 million.
  • Return on equity was 0.96% and debt-to-equity 0.01.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 5.55 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Ascent Industries Co. (ACNT) Latest News

13 May

Impact 4 · transcript

5 Mar

Impact 4 · transcript
stockrow.com/ACNT · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com